Sorry, you need to enable JavaScript to visit this website.

Competitive Grants Program

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Epidemiology and surveillance of Gram-negative infections caused by carbapenemase-producing organisms (CPOs) in the UK
    Release Date:
    Review Process: Expert Review Panel
    Research Internal Medicine United Kingdom
    Advancing Care for Patients with Advanced ALK+ Non-Small Cell Lung Cancer (NSCLC)
    Release Date:
    Partner: ALK Positive
    Review Process: Pfizer Internal
    Education Oncology All
    Quality Improvement Solutions for the Diagnosis and Management of Migraine and Headache Disorders
    Release Date:
    Partner: American Headache Society
    Review Process: Expert Review Panel
    Quality Improvement Internal Medicine Canada, USA
    Shared Decision Making in Hemophilia Patient Care
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Rare Disease China
    Real-World Atopic Dermatitis: Italian Insights Grant
    Release Date:
    Review Process: Expert Review Panel
    Research Inflammation & Immunology Italy
    Evolving Treatment Options in First-Line Metastatic Urothelial Carcinoma (mUC) and Muscle Invasive Bladder Cancer (MIBC)
    Release Date:
    Partner: Astellas
    Review Process: Pfizer Internal
    Education Oncology All
    Optimizing Care for patients with Muscle Invasive Bladder Cancer (MIBC)
    Release Date:
    Review Process: Expert Review Panel
    Translation: French (link)
    Quality Improvement Oncology Canada
    Optimizing HRRm Testing and Workflow Integration in mCSPC
    Release Date:
    Review Process: Expert Review Panel
    Translation: French (link)
    Quality Improvement, Research Oncology Canada
    Driving Timely Biomarker Testing to Optimize Treatment Decisions for Colorectal Cancer Patients Across Canada
    Release Date:
    Partner: Colorectal Cancer Canada (CCC)
    Review Process: Expert Review Panel
    Translation: French (link)
    Quality Improvement, Research Oncology Canada
    Antimicrobial Stewardship —Treatment optimization under antibiotics appropriate use policy in China
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology China
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Cardiac Transthyretin Amyloid (ATTR) Fellowship
    Release Date:
    Partner: International Society of Amyloidosis
    Review Process: Expert Review Panel
    Fellowship Rare Disease All
    Early Diagnosis of Invasive Fungal Infections(Europe, Australia, New Zealand, Korea and Japan)
    Release Date:
    Review Process: Pfizer Internal
    Research Hospital All
    Pfizer and RCNi – Providing Access to Learning Resources for Nurses in Emerging Markets Asia
    Release Date:
    Partner: RCNi
    Review Process: Expert Review Panel
    Education Support for the Professions Hong Kong, India, Indonesia, Malaysia, Pakistan, Philippines, Singapore, Taiwan, Thailand, Vietnam
    Improving Real-World Evidence & Data Generation Skills in Latin America
    Release Date:
    Review Process: Pfizer Internal
    Education Support for the Professions All
    Optimizing Venous Thromboembolism Management in Latin America
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Internal Medicine All
    Alopecia Areata, Atopic Dermatitis and Vitiligo (Global)
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology All
    Relapsed/Refractory Multiple Myeloma
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Antimicrobial Stewardship (AMS) Programs to Address Health Inequities in Resource Limited Settings
    Release Date:
    Partner: Global Bridges at Mayo Clinic
    Review Process: Expert Review Panel
    Quality Improvement Hospital All
    Increase HCP knowledge of Gene Therapy management
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease China
    Burden of Pneumococcal Disease - Analyzing Local Surveillance Data (Asia, Africa, Latin America, and Middle East)
    Release Date:
    Review Process: Pfizer Internal
    Research Vaccines All
    Pre-clinical & Translational Research in Multiple Myeloma
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology All
    Best Practices in HR+HER2-Metastatic Breast Cancer Medical Management Latin America,Africa,Middle East,Asia Pacific except China
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All